02.08.2013
- British drugmaker AstraZeneca warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expiries on key medicines. The prediction...
16.07.2013
- Simon Lowth is to quit as chief financial officer at AstraZeneca and return to his energy roots in the same role at BG Group after being passed over for the top job at the...
10.07.2013
- British pharmaceutical company AstraZeneca has agreed its first research partnerships in Cambridge for cancer treatments ahead of its relocation to the university city by 2016. The...
19.06.2013
- Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief...
18.03.2013
- Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...
18.03.2013
- AstraZeneca is to cut around 1,600 jobs as it overhauls research operations and consolidates drug development work in three major centres in Britain, the United States and Sweden...
18.03.2013
- AstraZeneca's new CEO Pascal Soriot, outlining his investment strategy for the ailing drugmaker this week, is unlikely to offer any quick fixes to plug a looming $6 billion sales...
31.01.2013
- AstraZeneca's new boss warned on Thursday the drugmaker faced a tough year in 2013, with sales expected to fall by a mid-to-high single digit percentage rate as patent expiries...
